Diagnostic Testing Market Size, Share & Trends Analysis Report by 2033
Laxman Dige
???????????? ???????????????? ?????????????? - ??????????????????????????????, & ???????????????????? | ?????????????????????? ?????? ?????????????? | ???????? ????????????????
According to recent study by nova one advisor, the global diagnostic testing market size was estimated at USD 211.27 billion in 2023 and is projected to hit around USD 449.78 billion by 2033, growing at a CAGR of 7.9% during the forecast period from 2024 to 2033.
The growth of the diagnostic testing market is propelled by several key factors. Firstly, technological advancements in fields such as biotechnology, genomics, and artificial intelligence have led to the development of increasingly sophisticated diagnostic tools, enhancing their accuracy and efficiency. Additionally, there is a growing emphasis on preventive healthcare initiatives, driving increased demand for screening and early detection methods. Moreover, the rising burden of chronic diseases globally, such as cancer, diabetes, and cardiovascular disorders, necessitates robust diagnostic infrastructure for timely intervention and management. Furthermore, the trend towards personalized medicine, which involves tailoring treatment strategies to individual genetic profiles, is fueling demand for genetic testing and precision diagnostics, further driving market growth. These factors collectively contribute to the expansion of the diagnostic testing market, shaping the future of healthcare delivery.
Get Sample Copy of Report@ https://www.novaoneadvisor.com/report/sample/6967
The U.S. Diagnostic Testing market size was valued at USD 84.85 billion in 2023 and is projected to surpass around USD 158.77 billion by 2033, registering a CAGR of 6.5% over the forecast period of 2024 to 2033.
The market for diagnostic tests is dominated by North America due to the region's growing elderly population. According to the Centers for Condition Control and Prevention (CDC), six out of ten individuals in the United States have at least one chronic disease, and four out of ten persons have two or more. The top causes of mortality and disability in the United States are chronic illnesses like cancer, heart disease, and diabetes, which also account for the majority of the USD 3.8 trillion in yearly health care expenses. As a result, there is now a greater need in the United States for better care that is managed effectively. Therefore, it is anticipated that the rising incidence of infectious and chronic illnesses as well as increased recognition of the importance of laboratory testing will drive market expansion in the nation.
Due to the availability of affordable diagnostic tests for chronic illnesses in the area, Asia-Pacific (APAC) is anticipated to have considerable growth during the forecast period of 2024 to 2033.
Diagnostic Testing Market, By Region ($ Billion) ? ? ? ?
Region 2020 2021 2022 2023 2024
North America : 73.19, 83.66, 92.76 , 87.88, 84.34
Europe: 46.33, 53.15, 59.08, 56.21, 54.16
Asia Pacific: 39.61, 46.05, 51.84, 49.94, 48.72
Latin America : 39.61, 46.05, 51.84 , 49.94, 48.72
MEA?:???5.69, 6.56, 7.35, 7.06 , 6.87??????
Diagnostic Testing Market Key Developments
Diagnostic Testing Market Players
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the Diagnostic Testing market.
By Type
By Application
By Approach
By Solution
By Technology
By Mode of Testing
By Sample Type
By Testing Type
By Age
By Distribution Channel
By End User
By Region
Immediate Delivery Available | Buy This Premium Research
Related Report
DNA Diagnostics Market: https://www.biospace.com/article/releases/dna-diagnostics-market-size-to-hit-usd-16-05-billion-by-2033/
领英推荐
Breast Cancer Diagnostics Market: https://www.biospace.com/article/breast-cancer-diagnostics-market-size-share-and-growth-report-2033/
Point Of Care Diagnostics Market: https://www.biospace.com/article/point-of-care-diagnostics-market-size-to-increase-usd-80-75-bn-by-2033/
Diagnostic Testing Market : https://www.biospace.com/article/releases/diagnostic-testing-market-size-to-reach-usd-449-78-billion-by-2033/
U.S. Biotechnology Market : https://www.biospace.com/article/releases/u-s-biotechnology-market-size-to-increase-usd-1-79-trillion-by-2033/
Oncology Market: The global oncology market size was estimated at USD 222.36 billion in 2023 and is projected to hit around USD 521.60 billion by 2033, growing at a CAGR of 8.9% during the forecast period from 2024 to 2033.
What is considered diagnostic testing?
Every time you go to a doctor with pain symptoms or an injury, chances are, your doctor will request that you undergo diagnostic testing. More than 13 billion diagnostic tests are performed every year in the United States. Diagnostic tests are used to confirm or rule out conditions and diseases.
Before creating a treatment plan, your doctor needs critical information for a correct diagnosis, which a diagnostic test can provide. So, what is considered diagnostic testing?
Diagnostic Testing
There are over 110 diagnostic tests and procedures currently in use. They are either used in detecting disease and for monitoring its progression. Moreover, diagnostic tools and equipment are also used in guiding treatment and evaluating its effectiveness.
Diagnostic tests are either invasive and non-invasive. Invasive diagnostic testing involves puncturing the skin or entering the body. Examples are taking a blood sample, biopsies, and colonoscopies. Non-invasive diagnostic testing does not involve making a break in the skin.
Diagnostic imaging procedures are prime examples of non-invasive diagnostic testing procedures. Non-invasive diagnostic testing usually involves the use of highly advanced diagnostic equipment that create images of organs, soft tissues, and bones inside the body without having to make an incision. Non-invasive diagnostic testing tools are often used to determine if more invasive procedures are needed to make a diagnosis.
Image-Guided Diagnostic Testing Procedures
Here are just a few of the most commonly used image-guided diagnostic testing procedures. Depending on your symptoms and doctor recommendations, any of these diagnostic tests could be useful to you:
X-Rays
Radiography or?X-ray?uses radiation and radio waves to create images of the bones and organs. X-ray was the very first diagnostic imaging tool used and is still the most widely used non-invasive diagnostic procedure today. For broken bones and chest obstructions, X-rays are usually the first requested medical imaging procedure.
MRI
A highly advanced diagnostic imaging procedure that creates images of the inner structures of the body without the use of radiation is?Magnetic Resonance Imaging (MRI). MRI uses a powerful magnet and radio waves to produce highly detailed images of what’s inside the body.
Ultrasound
An?ultrasound?uses sound waves, a transducer, and a computer to create images of the internal organs. It is most well-known as a tool used by obstetricians, but it has more applications than that. It is also used in treatment, particularly ultrasound-guided treatments for pain.
Mammography
Mammography?is used as a screening and diagnostic tool for women to detect abnormal growths in the breast. With the digitization of mammography, radiation exposure is cut down to very low dosages.
Diagnostic Testing in Palm Beach County, Florida
Independent Imaging?has ACR-accredited diagnostic testing facilities, where we make the best and most advanced diagnostic testing procedures available to you. We believe in delivering patient-centered care and place your comfort and convenience above everything else.
Our compassionate team of?radiologists?and assistants have a gentle and caring manner because we know how anxiety-inducing undergoing a diagnostic procedure can be.
Immediate Delivery Available, Get Full Access@
Type Insights
At order to diagnose or identify any illness or other medical disorders, clinical diagnostics encompasses all medical tests carried out in a pathology lab, diagnostic centre, hospital, or any other type of medical institution. These tests aid in the early identification of diseases and the identification of risk factors linked to such diseases, providing chances for both prevention and therapy. The rise in sedentary-related illnesses including diabetes, cardiovascular disease, high blood pressure, and lipid disorders, among others, is what motivates the development of clinical diagnostic tests. Additionally, it is anticipated that the number of patients with cancer and chronic renal disease would rise in the next years, propelling the market for clinical diagnostics. Additionally, advantages related to clinical diagnostics are predicted to drive the market through 2026, including rapid test results, simple testing procedures, simplicity of obtaining samples, and reduced discomfort.
Home diagnostics, often known as at-home diagnostics, allows patients or users to do various tests on-site at their homes. These test kits are often used to monitor an existing medical condition, identify a medical disease that has gone undetected, or provide information about a person's specific health characteristics. The continuous efforts to increase people's involvement in their healthcare benefit greatly from these testing. It is crucial that the findings are precise and simple for people to acquire. The global market for home diagnostic tests is largely driven by the expanding need for diagnostics brought on by the global geriatric population as well as the rising prevalence of different chronic illnesses. The popularity of diagnostic kits for at-home usage has expanded as a result of technical developments. The market for home diagnostics is fuelled by a number of factors, including the increasing use of telemedicine, the decline in healthcare costs, and the convenience of at-home use.
Approach Insights
The diagnostic tests market is divided into molecular diagnostic tools, in-vitro diagnostic tools, and point-of-care testing tools based on technique. Since in-vitro diagnostics are increasingly used to test samples like blood and saliva to diagnose illnesses or other disorders, the in-vitro diagnostic instrument sector is predicted to dominate the market. Additionally, the frequency of infectious and chronic illnesses is anticipated to rise during the projection period along with the ongoing expansion in the senior population.
The global response to the pandemic has been greatly aided by?molecular diagnostic?testing for COVID-19. Government agencies from all around the world are assisting laboratories in expediting COVID-19 testing procedures since testing is still an essential step in slowing the disease's fast spread. Accordingly, regulatory agencies used techniques to hasten the licencing of molecular diagnostic tools. As diagnostic testing continues to be the foundation of the COVID-19 response, supporting containment efforts to reduce the outbreak, significant corporations have also made strategic innovations to deploy COVID-19 quick tests and neutralise the influence of COVID-19 on their operating capabilities. Additionally, due to the severity of the crisis and growing capacity problems with PCR-based testing, diagnostic solutions were developed more quickly to fulfil the need for mass testing.
Tests for?in-vitro diagnostics?are conducted using human blood or tissue samples. This kind of diagnostic testing is mostly used to find infections, illnesses, and disorders. In-vitro diagnostics are used in precision medicine today to identify individuals who need certain medications or treatments. With the availability of trained experts and infrastructure development, in-vitro diagnostics tests are often performed in laboratories and healthcare institutions. In the upcoming years, a growing number of pathology laboratories and services outfitted with cutting-edge diagnostic equipment are anticipated to fuel market expansion.
The research (diagnosis & monitoring) of a variety of diseases, such as cancer, diabetes, heart disorders, and others, uses point-of-care (POC) diagnostics, which are medical tools used to obtain an instantaneous response. Due to the frequency of chronic and infectious illnesses in developing nations, the?point-of-care diagnostics market?is expanding. Globally, the prevalence of chronic illnesses including diabetes, rheumatism, and cancer is rising for a number of reasons, including an ageing population, sedentary lifestyles, poor dietary habits, and environmental factors.
Application Insights
The diagnostic tests market is divided into categories based on application, including cardiology,?oncology, neurology, orthopaedics, gastrointestinal, gynaecology, odontology, and others. Due to the global rise in heart patients and other cardiovascular disorders, the cardiology segment is predicted to dominate the market. The majority of cardiovascular disorders require diagnostic testing in order to be identified and treated. Cardiovascular diagnostic testing can reveal details about the electrical activity of the heart, the rhythm of the heartbeat, the efficiency with which blood pumps through the heart's chambers and valves, the ease with which blood flows through the coronary arteries to the heart muscle, and the presence of tumours or structural abnormalities in the cardiovascular system. The risk factors for heart disease are found via laboratory testing. These include the measurement of blood lipids such as LDL, HDL, and triglycerides as well as fats, cholesterol, and lipid components. For the diagnosis of diabetes, blood sugar and glycosylated haemoglobin levels are tested.
End User Insights
The diagnostic tests market is divided into hospitals, diagnostic centres, research laboratories and institutes, research institutions, homecare, blood banks, specialised clinics, ambulatory surgery centres, and others based on the end user. As hospitals perform a variety of diagnostic tests, including glucose tests, infectious diseases tests, cytology tests, CBC tests, blood culture tests, syphilis tests, urea tests, C-reactive protein tests, antigen tests, and HBA1C tests, causing for the detection and treatment of serious diseases or other major conditions, the hospitals segment is anticipated to dominate the market.
Key Market Developments
Immediate Delivery Available | Buy This Premium Research
Call: USA: +1 650 460 3308 | IND: +91 87933 22019 |Europe: +44 2080772818
Email: [email protected]